Goldman Sachs Group Inc. Raises Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Goldman Sachs Group Inc. boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 454,793 shares of the company’s stock after acquiring an additional 22,290 shares during the period. Goldman Sachs Group Inc. owned 0.49% of Acadia Healthcare worth $35,365,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. GAMMA Investing LLC purchased a new position in Acadia Healthcare in the fourth quarter worth about $26,000. Fifth Third Bancorp raised its holdings in Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after buying an additional 136 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare in the third quarter worth about $96,000. Headlands Technologies LLC raised its holdings in Acadia Healthcare by 422.3% in the fourth quarter. Headlands Technologies LLC now owns 1,828 shares of the company’s stock worth $142,000 after buying an additional 1,478 shares during the last quarter. Finally, Capstone Investment Advisors LLC purchased a new position in Acadia Healthcare in the fourth quarter worth about $204,000.

Acadia Healthcare Trading Up 1.5 %

Shares of NASDAQ:ACHC opened at $68.62 on Friday. Acadia Healthcare Company, Inc. has a 12-month low of $62.04 and a 12-month high of $87.77. The company has a market cap of $6.37 billion, a PE ratio of -490.11, a price-to-earnings-growth ratio of 2.05 and a beta of 1.32. The stock has a 50 day moving average of $68.76 and a 200 day moving average of $76.07. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. During the same quarter in the previous year, the firm earned $0.75 earnings per share. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ACHC shares. TD Cowen decreased their target price on shares of Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating for the company in a report on Friday, May 17th. Mizuho reduced their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target for the company in a research note on Thursday, April 25th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Finally, UBS Group lifted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $87.56.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.